©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Figure 5 He-He-Shu-Yang formula inhibits transforming growth factor-beta 1-induced activation of the human hepatic stellate cell line (LX2).
bP < 0.01 vs control group; dP < 0.01 vs model group. Data are mean ± SD. A: Representative images of immunofluorescence staining of α-smooth muscle actin (α-SMA) in LX2 cells; B: Mean fluorescence intensity of α-SMA; C: Relative ACTA2 (which encodes α-SMA) mRNA levels. α-SMA: Α-smooth muscle actin; AU: Arbitrary unit.
- Citation: Zeng FL, Shi MJ, Mo YS, Xiao HM, Xie YB, Chi XL. He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro. World J Hepatol 2025; 17(12): 112835
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/112835.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.112835